Legal Status & Legality
A detailed legal analysis of the situation in Germany, the EU and other international legal areas based on historical evidence and current official practice
Contents

Premium Noble Kava
Discover certified quality and purity with our official partner.
Visit Kava-mode.comThe legal situation of Kava (Piper methysticum) in Europe is often confused with the old medicinal drug debate. However, for the Novel Food question, it is crucial whether Kava was used in the EU in a significant amount before May 15, 1997. The documented market, approval, and usage history clearly support from our legal perspective: Kava is not a Novel Food and is generally marketable as a food, provided it is not marketed as a medicinal product.
The Novel Food Status
The key question for the marketability of Kava as a food or dietary supplement in the EU is not whether Kava was ever subject to complaints, but whether it was already used in the EU for human consumption in a significant amount before May 15, 1997. It is precisely this historical proof that determines the Novel Food classification.
The result of the documented evidence is clear from our perspective: Kava is not a Novel Food. Subsequent authorities' practices, enforcement differences, or individual complaints do not change this pre-1997 usage.
- Medicinal approval before 1997: Kava was established in Germany long before 1997 as a herbal medicinal product; the Commission E published a positive monograph in 1990.
- Market presence: The ETC/RAFI documentation already describes ongoing marketing of Kava extracts by numerous companies in Europe in the mid-1990s.
- Distribution: Products like “Antares” or “Kavasporal forte” demonstrate that Kava was not just theoretically but practically present on the market before the cutoff date.
- No approval requirement: If the historical prior use before 1997 is proven, the approval requirement for Novel Food does not apply.
- Marketability: Kava can be assessed and marketed under food law; the critical factors are composition, labeling, and marketing form, not a blanket claim of novelty.
- Burden of proof: Even if authorities or market participants demand evidence, the historical documentation is strong enough to substantiate the prior use before 1997.
The Situation in Germany
Germany has a special history with Kava. For the current classification, it is important not to confuse medicinal law, authorities' practice, and the separate Novel Food question.
Phase 1: The Golden Age (until 2001)
Kava was an established herbal remedy. The Commission E confirmed its efficacy for nervous anxiety in 1990. Numerous approved preparations were available in pharmacies and on the market.
Phase 2: The Ban in Medicinal Area (2002–2014)
Due to suspected cases of liver damage, BfArM withdrew approvals for Kava medicinal products in 2002. This debate concerned the medicinal product sector and is not identical with the food law Novel Food question.
Phase 3: Courts, Conditions, and New Authority Line (from 2014/2019/2024)
In 2014/2015, courts declared the earlier revocation unlawful; in 2015, BfArM initially ordered risk-reducing modifications. In 2019, BfArM revoked approvals in the medicinal sector again. A further court decision in 2024 was regarded by the Kava Coalition as an important step toward legalization. However, for the Novel Food question, it remains crucial that Kava was already present, approved, and used in Germany long before 1997.
Distinction: Medicinal Product vs. Food
Kava must not be sold as a medicinal product with health claims without proper approval in Germany. However, this does not automatically mean Kava as a food is new or not marketable. Product presentation, intended purpose, and the documented usage history before 1997 are decisive.
Merchants must not make health-related claims like “helps against anxiety disorder,” as this can make the product a presentation medicinal. Statements about tradition, preparation, culture, or general relaxation are evaluated differently under food law.
The EU Legal Situation
At the EU level, there is no uniform total ban on Kava. However, practices vary between member states. The crucial distinction is between medicinal law, food law, and enforcement. From the documented prior use perspective, the evidence clearly argues against a classification as a Novel Food; enforcement differences do not alter this historical baseline.
Legal Status in Europe
Note: This map is for orientation only and does not constitute legal advice. Laws may change.
| Country | Status | Details |
|---|---|---|
| Germany | Legal | Generally marketable as food/dietary supplement; the earlier debate mainly concerned medicinal products. |
| Poland | Legal | The old ban was explicitly lifted in 2018. Kava is freely available. |
| United Kingdom | Restricted | Sale for human consumption still officially restricted, possession and import for personal use often tolerated. |
| France | Grey zone | Strict enforcement, but no new historical evidence against pre-1997 documented use. |
Download the complete legal opinion on the classification of Kava as a Novel Food here. It consolidates the historical usage, pre-1997 evidence, and legal arguments against a Novel Food classification. Available in German and English.
Copyright Notice & Terms of Use:
The legal opinion was commissioned by Kava-Mode.com.
Conclusion & Recommendation
The old panic-mongering of the early 2000s mixes medicinal law, safety debates, and Novel Food questions. The documented prior use clearly indicates that Kava is not a Novel Food. For consumers and merchants, clean product quality, transparent labeling, and marketing without unapproved health claims are essential. Those who focus on quality, origin, and Noble Kava are much closer to a reliable and serious product practice than those who dismiss Kava as unfit for food use.
Current Development: USA (January 2026)
The US FDA issued an important clarification in January 2026:
- Traditionally prepared Kava beverages (water infusion of Kava roots) are considered conventional foods under US federal law
- Capsules, tinctures, and concentrated extracts remain regulated as dietary supplements
- The distinction is based on the traditional preparation method and lower kavalactone concentrations in water extracts
- This paves the way for Kava beverages in the US mainstream market alongside teas and functional drinks
LA County, California: Official Clarification (February 2026)
The Los Angeles County Department of Public Health issued an important clarification on Kava status in February 2026:
- Traditionally water-prepared Kava tea is officially permitted as a conventional food in LA County
- The sale of correctly labeled Kava dietary supplements (prepackaged, with Supplement Facts label) is also allowed
- The Kava Coalition welcomed the decision as an important step for legal certainty in the California market
- This follows the FDA clarification from January 2026 and strengthens Kava's position locally
New Zealand: Planned Kava Reforms (2026)
The New Zealand Ministry for Primary Industries (MPI) plans a comprehensive adjustment of the Kava food standards:
- Ban on non-Noble varieties (such as Tudei Kava) for the food market
- Prohibition of food additives in Kava products
- Alignment with Australian standards and WHO recommendations
- Pacific leaders generally support the reforms
- Concerns from small farmers in Tonga who could be excluded from the market due to stricter rules
Fiji: First Kava Law in Preparation (2026)
Fiji, one of the main Kava producers, is working on its first national Kava law:
- Protection for growers, processors, and exporters
- Quality standards for export
- Regulation of the growing industry
- Initial consultations began in February 2026
Fiji: Kava Exports at Record High (2024/2025)
Fiji's Kava industry shows strong growth:
- Kava exports reached a record value of 53 million FJD in 2024
- The government increased funding for Kava cultivation to 1.9 million FJD significantly
- Targeted export goal: 250 million FJD by 2028
- The US Kava market is estimated at over 1 billion USD
Sources & References
- <a href="/downloads/kava_novel_food_rechtsgutachten.pdf" target="_blank" rel="noopener noreferrer">Legal opinion on the classification of Kava as a Novel Food (2025), GFY Babilon LLP</a>
- <a href="https://food.ec.europa.eu/food-safety/novel-food/novel-food-status-catalogue_en" target="_blank" rel="noopener noreferrer">European Commission: Novel Food Status Catalogue</a>
- <a href="https://www.bvl.bund.de/SharedDocs/Downloads/01_Lebensmittel/Internationales/Report_HoA_WG_FS-de.pdf?__blob=publicationFile&v=8" target="_blank" rel="noopener noreferrer">HoA Working Group “Food Supplements” / BVL (2024)</a>
- Commission E Monograph, Federal Gazette No. 101 of 1.6.1990
- ETC Group / RAFI Communiqué: "The Kava Boom" (1996/1997)
- <a href="https://www.ovg.nrw.de/behoerde/presse/pressemitteilungen/01_archiv/2015/12_150225/index.php" target="_blank" rel="noopener noreferrer">OVG NRW: Revocation of approval of Kava-Kava medicinal products unlawful (2015)</a>
- <a href="https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RV_STP/g-l/kavakava.html" target="_blank" rel="noopener noreferrer">BfArM: Kava-Kava medicinal products (2019)</a>
- <a href="https://www.globenewswire.com/news-release/2024/08/13/2928871/0/de/Kava-Coalition-feiert-Gerichtsentscheidung-zur-Ebnung-des-Weges-f%C3%BCr-die-Legalisierung-von-Kava-in-Deutschland.html" target="_blank" rel="noopener noreferrer">GlobeNewswire / Kava Coalition: Court decision paving the way for legalization of Kava in Germany (August 2024)</a>
- <a href="https://food.ec.europa.eu/document/download/c5153710-6c3e-4f81-8dc5-2587d81d8bc8_en?filename=ff_ffn_monthly-report_202503.pdf" target="_blank" rel="noopener noreferrer">European Commission: Monthly report on EU Agri-Food Fraud suspicions (March 2025)</a>
- Regulation (EU) 2015/2283 on novel foods
- <a href="https://grctimes.com/fda-kava-ruling-conventional-food-under-federal-law-safety-evidence-historical-use/" target="_blank" rel="noopener noreferrer">FDA Kava Ruling (January 2026) - Classification as a conventional food</a>
- <a href="https://www.fijitimes.com.fj/move-to-regulate-yaqona-industry/" target="_blank" rel="noopener noreferrer">The Fiji Times: Move to regulate yaqona industry (February 2026)</a>
- <a href="https://www.reflector.com/news/national/kava-coalition-applauds-los-angeles-county-department-of-public-health-update-clarifying-the-status-of/article_1118588e-75c8-51eb-80d3-46d57f8c733f.html" target="_blank" rel="noopener noreferrer">Kava Coalition: LA County Department of Public Health Update (February 2026)</a>
- <a href="https://pmn.co.nz/read/health/pacific-leaders-back-kava-reforms-but-warn-of-risks-for-small-growers" target="_blank" rel="noopener noreferrer">Pacific Media Network: NZ Kava Reforms (February 2026)</a>
- <a href="https://nit.com.au/06-02-2026/22528/fiji-boosts-kava-funding-as-exports-hit-record-53-million" target="_blank" rel="noopener noreferrer">National Indigenous Times: Fiji Kava Exports Record (February 2026)</a>
Frequently Asked Questions about Legality (FAQ)
Scientific Sources
The information on this page is based on the following scientific studies and publications:

